Literature DB >> 33146382

Prostate Cancer Screening Guidelines for Black Men: Spotlight on an Empty Stage.

Ruth Etzioni1, Yaw A Nyame1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33146382      PMCID： PMC8168118          DOI： 10.1093/jnci/djaa172

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  20 in total

1.  Screening Men at Increased Risk for Prostate Cancer Diagnosis: Model Estimates of Benefits and Harms.

Authors:  Roman Gulati; Heather H Cheng; Paul H Lange; Peter S Nelson; Ruth Etzioni
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-10-14       Impact factor: 4.254

2.  Screening for prostate cancer decreases the risk of developing metastatic disease: findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC).

Authors:  Fritz H Schröder; Jonas Hugosson; Sigrid Carlsson; Teuvo Tammela; Liisa Määttänen; Anssi Auvinen; Maciej Kwiatkowski; Franz Recker; Monique J Roobol
Journal:  Eur Urol       Date:  2012-06-07       Impact factor: 20.096

3.  Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.

Authors:  Gerald L Andriole; E David Crawford; Robert L Grubb; Saundra S Buys; David Chia; Timothy R Church; Mona N Fouad; Claudine Isaacs; Paul A Kvale; Douglas J Reding; Joel L Weissfeld; Lance A Yokochi; Barbara O'Brien; Lawrence R Ragard; Jonathan D Clapp; Joshua M Rathmell; Thomas L Riley; Ann W Hsing; Grant Izmirlian; Paul F Pinsky; Barnett S Kramer; Anthony B Miller; John K Gohagan; Philip C Prorok
Journal:  J Natl Cancer Inst       Date:  2012-01-06       Impact factor: 13.506

4.  Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations.

Authors:  Ahmedin Jemal; Stacey A Fedewa; Jiemin Ma; Rebecca Siegel; Chun Chieh Lin; Otis Brawley; Elizabeth M Ward
Journal:  JAMA       Date:  2015-11-17       Impact factor: 56.272

5.  Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.

Authors:  Fritz H Schröder; Jonas Hugosson; Monique J Roobol; Teuvo L J Tammela; Marco Zappa; Vera Nelen; Maciej Kwiatkowski; Marcos Lujan; Liisa Määttänen; Hans Lilja; Louis J Denis; Franz Recker; Alvaro Paez; Chris H Bangma; Sigrid Carlsson; Donella Puliti; Arnauld Villers; Xavier Rebillard; Matti Hakama; Ulf-Hakan Stenman; Paula Kujala; Kimmo Taari; Gunnar Aus; Andreas Huber; Theo H van der Kwast; Ron H N van Schaik; Harry J de Koning; Sue M Moss; Anssi Auvinen
Journal:  Lancet       Date:  2014-08-06       Impact factor: 79.321

6.  Radical Prostatectomy or Observation for Clinically Localized Prostate Cancer: Extended Follow-up of the Prostate Cancer Intervention Versus Observation Trial (PIVOT).

Authors:  Timothy J Wilt; Tien N Vo; Lisa Langsetmo; Philipp Dahm; Thomas Wheeler; William J Aronson; Matthew R Cooperberg; Brent C Taylor; Michael K Brawer
Journal:  Eur Urol       Date:  2020-02-21       Impact factor: 20.096

7.  African American Race is Not Associated with Risk of Reclassification during Active Surveillance: Results from the Canary Prostate Cancer Active Surveillance Study.

Authors:  Jeannette M Schenk; Lisa F Newcomb; Yingye Zheng; Anna V Faino; Kehao Zhu; Yaw A Nyame; James D Brooks; Peter R Carroll; Matthew R Cooperberg; Atreya Dash; Christopher P Filson; Martin E Gleave; Michael Liss; Francis M Martin; Todd M Morgan; Peter S Nelson; Ian M Thompson; Andrew A Wagner; Daniel W Lin
Journal:  J Urol       Date:  2019-10-25       Impact factor: 7.450

8.  Clinical outcomes in men of diverse ethnic backgrounds with metastatic castration-resistant prostate cancer.

Authors:  S Halabi; S Dutta; C M Tangen; M Rosenthal; D P Petrylak; I M Thompson; K N Chi; J S De Bono; J C Araujo; C Logothetis; M A Eisenberger; D I Quinn; K Fizazi; M J Morris; C S Higano; I F Tannock; E J Small; W K Kelly
Journal:  Ann Oncol       Date:  2020-04-11       Impact factor: 32.976

9.  Racial and Ethnic Variation in PSA Testing and Prostate Cancer Incidence Following the 2012 USPSTF Recommendation.

Authors:  Kevin H Kensler; Claire H Pernar; Brandon A Mahal; Paul L Nguyen; Quoc-Dien Trinh; Adam S Kibel; Timothy R Rebbeck
Journal:  J Natl Cancer Inst       Date:  2021-06-01       Impact factor: 13.506

10.  Comparison by Race of Conservative Management for Low-Risk and Intermediate-Risk Prostate Cancers in Veterans From 2004 to 2018.

Authors:  Ravi B Parikh; Kyle W Robinson; Sumedha Chhatre; Elina Medvedeva; John P Cashy; Shika Veera; Joshua M Bauml; Tito Fojo; Amol S Navathe; S Bruce Malkowicz; Ronac Mamtani; Ravishankar Jayadevappa
Journal:  JAMA Netw Open       Date:  2020-09-01
View more
  2 in total

1.  Harm-to-Benefit of Three Decades of Prostate Cancer Screening in Black Men.

Authors:  Spyridon P Basourakos; Roman Gulati; Randy A Vince; Daniel E Spratt; Patrick J Lewicki; Alexander Hill; Yaw A Nyame; Jennifer Cullen; Sarah C Markt; Christopher E Barbieri; Jim C Hu; Erika Trapl; Jonathan E Shoag
Journal:  NEJM Evid       Date:  2022-05-15

2.  The Impact of Intensifying Prostate Cancer Screening in Black Men: A Model-Based Analysis.

Authors:  Yaw A Nyame; Roman Gulati; Eveline A M Heijnsdijk; Alex Tsodikov; Angela B Mariotto; John L Gore; Ruth Etzioni
Journal:  J Natl Cancer Inst       Date:  2021-10-01       Impact factor: 11.816
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.